PharmaCyte Biotech, Inc.
PMCB · XNASCIK 1157075fmd_0NBYESKYAH8YVF5KHFTX0J9KBCManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: May 01, 2010 to Jul 31, 2026, 65 periods
Latest annual · FY2026
Millions- Total revenues
- 0
- Operating income
- (7)
- Net income
- (19)
Latest quarter · Q1 FY2027
Millions- Total revenues
- 0
- Operating income
- (1)
- Net income
- (5)
Daily close · PMCBIEX trades only
Apr 02, 2025 to Nov 11, 2026 · 250 sessions0.43 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2023 to FY2026
- n/m
- Revenue, 5 yearsFY2021 to FY2026
- n/m
- Net income, 5 yearsFY2021 to FY2026
- n/m
PharmaCyte Biotech, Inc. (PMCB) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2026-07-29 · proof | |
| Operating income | -$6.9 million | -$4.4 million | 10-K 2026-07-29 · proof | |
| Net income | -$19.4 million | $30.7 million | -163.4% | 10-K 2026-07-29 · proof |
| Cash from operating activities | -$5.2 million | -$3 million | 10-K 2026-07-29 · proof | |
| Total assets | $46.8 million | $55.2 million | -15.3% | 10-K 2026-07-29 · proof |
| Total liabilities | $11.8 million | $3.3 million | +259.2% | 10-K 2026-07-29 · proof |
| Cash and cash equivalents | $18.6 million | $15.2 million | +22.6% | 10-K 2026-07-29 · proof |
- What was PharmaCyte Biotech, Inc. (PMCB)'s revenue in fiscal 2026?
- PharmaCyte Biotech, Inc. (PMCB) reported revenue of $0 for fiscal 2026 (the year ended Apr 30, 2026), against $0 the year before. Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was PharmaCyte Biotech, Inc. (PMCB)'s operating income in fiscal 2026?
- PharmaCyte Biotech, Inc. (PMCB) reported operating income of -$6.9 million for fiscal 2026 (the year ended Apr 30, 2026), against -$4.4 million the year before. Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was PharmaCyte Biotech, Inc. (PMCB)'s net income in fiscal 2026?
- PharmaCyte Biotech, Inc. (PMCB) reported net income of -$19.4 million for fiscal 2026 (the year ended Apr 30, 2026), against $30.7 million the year before (-163.4%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What was PharmaCyte Biotech, Inc. (PMCB)'s cash from operating activities in fiscal 2026?
- PharmaCyte Biotech, Inc. (PMCB) reported cash from operating activities of -$5.2 million for fiscal 2026 (the year ended Apr 30, 2026), against -$3 million the year before. Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are PharmaCyte Biotech, Inc. (PMCB)'s total assets?
- As of Apr 30, 2026, PharmaCyte Biotech, Inc. (PMCB) reported total assets of $46.8 million, against $55.2 million a year earlier (-15.3%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are PharmaCyte Biotech, Inc. (PMCB)'s total liabilities?
- As of Apr 30, 2026, PharmaCyte Biotech, Inc. (PMCB) reported total liabilities of $11.8 million, against $3.3 million a year earlier (+259.2%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
- What are PharmaCyte Biotech, Inc. (PMCB)'s cash and cash equivalents?
- As of Apr 30, 2026, PharmaCyte Biotech, Inc. (PMCB) reported cash and cash equivalents of $18.6 million, against $15.2 million a year earlier (+22.6%). Source: the 10-K filed with the SEC on Jul 29, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PMCB&period_type=annual&limit=5"Information only, not investment advice.